Pinnacle Bancorp’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3K Buy
+180
New +$15.1K ﹤0.01% 664
2025
Q2
Sell
-90
Closed -$6.52K 919
2025
Q1
$6.52K Sell
90
-614
-87% -$43.9K ﹤0.01% 748
2024
Q4
$52.1K Sell
704
-123
-15% -$8.61K 0.02% 416
2024
Q3
$54.6K Hold
827
0.01% 407
2024
Q2
$76.4K Hold
827
0.02% 324
2024
Q1
$79K Sell
827
-132
-14% -$11.1K 0.02% 325
2023
Q4
$73.1K Buy
959
+100
+12% +$6.96K 0.02% 322
2023
Q3
$59.5K Hold
859
0.02% 341
2023
Q2
$81K Hold
859
0.03% 285
2023
Q1
$71.1K Hold
859
0.03% 303
2022
Q4
$64K Buy
859
+107
+14% +$8.25K 0.02% 304
2022
Q3
$62K Buy
752
+51
+7% +$4.91K 0.03% 294
2022
Q2
$67K Hold
701
0.03% 281
2022
Q1
$83K Buy
701
+110
+19% +$12.3K 0.03% 268
2021
Q4
$77K Sell
591
-42
-7% -$4.9K 0.03% 284
2021
Q3
$72K Sell
633
-215
-25% -$24.5K 0.03% 285
2021
Q2
$88K Hold
848
0.04% 259
2021
Q1
$71K Hold
848
0.03% 282
2020
Q4
$77K Hold
848
0.05% 267
2020
Q3
$68K Sell
848
-553
-39% -$43.1K 0.05% 264
2020
Q2
$97K Hold
1,401
0.07% 202
2020
Q1
$88K Buy
1,401
+123
+10% +$8.87K 0.08% 197
2019
Q4
$99K Sell
1,278
-87
-6% -$6.79K 0.07% 211
2019
Q3
$100K Buy
1,365
+87
+7% +$6.11K 0.06% 205
2019
Q2
$79K Hold
1,278
0.04% 237
2019
Q1
$82K Hold
1,278
0.05% 236
2018
Q4
$65K Buy
+1,278
New +$64.7K 0.04% 247

Other funds holding EW

Pinnacle Bancorp's EW Position: Q2 2026 in Review

Pinnacle Bancorp opened a new position in Edwards Lifesciences (EW) in Q2 2026: 180 shares worth $16.3K. The stake represents ﹤0.01% of the portfolio and ranks #664 among its holdings. This is a return to the name: Pinnacle Bancorp previously reported a position in EW as recently as Q1 2025.

Pinnacle Bancorp first reported a position in EW in Q4 2018 and has held it in 27 quarters since. The position peaked at $100K in Q3 2019. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Pinnacle Bancorp held 180 shares of Edwards Lifesciences worth $16.3K as of Q2 2026.
  • Edwards Lifesciences was a new Pinnacle Bancorp position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #664 holding.
  • Pinnacle Bancorp first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 27 quarters since.
  • Pinnacle Bancorp's Edwards Lifesciences position peaked at $100K in Q3 2019.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.